▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁ther 8.0078125
apy 0.33935546875
▁by 5.26171875
▁comparing 7.94921875
▁the 0.9873046875
▁effects 2.169921875
▁of 0.0303192138671875
▁ph 2.455078125
arma 0.039642333984375
ce 0.0011568069458007812
ut 7.176399230957031e-05
ical 0.00390625
▁op 0.305419921875
io 0.162841796875
ids 0.058685302734375
▁and 0.275390625
▁MM 1.2138671875
. 1.0
<0x0A> 1.0068359375
The 1.3349609375
▁study 2.015625
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4443359375
▁form 2.197265625
▁of 0.006374359130859375
▁collection 10.03125
▁and 1.6943359375
▁analysis 0.6806640625
▁of 0.04559326171875
▁statistical 4.203125
▁data 0.120361328125
. 0.89599609375
▁Part 4.94921875
icip 0.06683349609375
ants 0.04595947265625
▁were 0.70361328125
▁rec 3.2578125
ru 0.0010690689086914062
ited 4.839897155761719e-05
▁for 4.05078125
▁six 7.5546875
▁months 0.52197265625
▁at 3.771484375
▁two 2.498046875
▁major 5.4453125
▁pain 3.078125
▁relief 5.24609375
▁cent 1.5498046875
ers 0.07904052734375
▁in 0.70947265625
▁Israel 4.3203125
. 0.41552734375
▁The 1.1923828125
▁research 2.166015625
ers 1.505859375
▁used 2.705078125
▁The 8.0625
▁De 4.21484375
pression 0.01334381103515625
▁Module 10.1171875
▁of 0.95947265625
▁the 0.32568359375
▁Pat 2.287109375
ient 0.007503509521484375
▁Health 0.08447265625
▁Question 0.013946533203125
naire 0.0183258056640625
▁and 3.3515625
▁the 0.73095703125
▁General 1.6826171875
ized 0.69140625
▁An 0.016021728515625
x 0.0001443624496459961
iety 0.002651214599609375
▁Dis 0.5146484375
order 0.034881591796875
▁Sc 1.205078125
ale 0.068359375
▁to 1.7373046875
▁interview 7.06640625
▁participants 2.017578125
, 3.697265625
▁evaluate 5.56640625
▁their 0.7431640625
▁answers 6.48828125
, 0.853515625
▁and 0.1422119140625
▁conduct 4.4453125
▁the 2.296875
▁study 2.2421875
. 0.224609375
▁To 5.09375
▁specifically 9.8828125
▁evaluate 2.580078125
▁and 4.35546875
▁compare 0.9423828125
▁the 0.338134765625
▁prob 11.1328125
abilities 0.1806640625
▁of 0.1295166015625
▁de 0.82421875
pression 0.03790283203125
▁or 4.5859375
▁anx 0.03558349609375
iety 0.0002944469451904297
▁among 1.7216796875
▁the 2.263671875
▁diverse 8.8984375
▁groups 1.564453125
, 1.4130859375
▁the 1.0107421875
▁study 2.673828125
▁used 1.623046875
▁multiple 4.734375
▁log 2.884765625
istic 0.03607177734375
▁regression 0.101318359375
▁analysis 0.6630859375
▁and 2.53125
▁chose 8.8984375
▁medical 7.41015625
▁mar 0.322021484375
iju 0.0015125274658203125
ana 0.00019562244415283203
▁as 0.794921875
▁the 1.083984375
▁control 2.7265625
▁group 0.5537109375
. 0.285888671875
<0x0A> 0.7548828125
This 3.498046875
▁type 6.078125
▁of 0.0064544677734375
▁study 1.6416015625
▁is 1.287109375
▁the 3.41796875
▁most 1.875
▁reve 9.1640625
aling 0.0006284713745117188
▁and 1.0576171875
▁inclus 6.453125
ive 0.0024356842041015625
, 2.328125
▁as 1.884765625
▁it 0.35546875
▁contains 4.9375
▁direct 6.359375
▁responses 4.9921875
▁from 0.8212890625
▁a 3.86328125
▁large 0.923828125
▁number 0.439208984375
▁of 0.003082275390625
▁participants 1.412109375
. 0.62939453125
▁All 4.63671875
▁tools 9.1328125
▁in 4.55859375
▁the 0.658203125
▁form 3.521484375
▁of 0.040771484375
▁question 1.7451171875
na 0.035858154296875
ires 9.489059448242188e-05
▁and 2.076171875
▁scales 3.046875
▁have 3.685546875
▁already 4.4765625
▁been 0.1802978515625
▁used 1.9365234375
▁and 2.080078125
▁proved 4.2265625
▁their 1.796875
▁effic 3.923828125
acy 7.462501525878906e-05
▁for 3.654296875
▁collect 4.59765625
ing 0.0174407958984375
▁analyt 8.265625
ical 0.238525390625
▁data 0.27392578125
. 0.417724609375
▁It 3.533203125
▁helps 4.7734375
▁to 0.97314453125
▁system 7.3125
at 1.322265625
ize 0.005832672119140625
▁and 1.580078125
▁class 4.07421875
ify 0.00213623046875
▁distinct 9.2265625
▁kinds 6.3046875
▁of 0.0241241455078125
▁information 3.419921875
▁for 3.923828125
▁subsequent 4.109375
▁un 8.0
comp 5.4140625
licated 0.058013916015625
▁services 11.78125
. 0.65087890625
▁Thus 4.4140625
, 0.0228271484375
▁research 4.46484375
ers 0.50927734375
▁can 1.3828125
▁compare 3.9609375
▁the 0.955078125
▁effects 3.0
▁of 0.1097412109375
▁medic 4.47265625
ations 0.8818359375
▁on 1.8232421875
▁patients 2.080078125
▁of 4.60546875
▁diverse 4.07421875
▁age 2.703125
▁groups 0.685546875
, 0.9208984375
▁background 5.01953125
s 0.2066650390625
, 0.06817626953125
▁physical 5.39453125
▁conditions 1.4140625
, 0.084716796875
▁emot 5.52734375
ional 0.0626220703125
▁states 1.3896484375
, 0.1026611328125
▁and 0.43505859375
▁so 3.203125
▁on 0.329833984375
. 0.08941650390625
<0x0A> 0.6474609375
The 1.08984375
▁analysis 4.5234375
▁of 0.58642578125
▁any 8.859375
▁human 6.09375
▁reaction 4.84765625
▁has 4.59765625
▁a 1.7421875
▁high 4.46875
▁potential 3.427734375
▁of 1.638671875
▁subject 6.06640625
iveness 3.8671875
▁and 1.341796875
▁bias 2.234375
, 1.9091796875
▁especially 2.37890625
▁regarding 4.3671875
▁people 4.46875
▁in 3.984375
▁severe 4.28125
▁pain 0.3017578125
▁and 2.6484375
▁un 5.34375
stable 1.826171875
▁emot 0.8173828125
ional 0.1700439453125
▁condition 2.583984375
. 0.0709228515625
▁Perhaps 8.9375
▁some 5.015625
▁patients 2.359375
▁tend 5.4296875
▁to 0.0198516845703125
▁ex 2.591796875
agger 0.0014495849609375
ate 0.005512237548828125
▁their 0.7490234375
▁de 5.1171875
press 1.365234375
ive 0.254150390625
▁state 3.10546875
▁or 1.88671875
▁vice 7.375
▁vers 0.014678955078125
a 4.4226646423339844e-05
, 1.0029296875
▁de 7.453125
- 4.90234375
emph 0.95068359375
as 0.00508880615234375
ize 0.11962890625
▁serious 6.59765625
▁difficulties 5.9140625
. 0.8837890625
▁Because 6.2109375
▁the 2.2890625
▁survey 6.1640625
▁responses 6.7421875
▁were 1.5947265625
▁thoroughly 7.81640625
▁anonymous 5.3203125
, 0.452392578125
▁the 1.4501953125
▁research 1.5302734375
ers 0.2841796875
▁were 1.44140625
▁unable 2.44140625
▁to 0.0031757354736328125
▁carefully 8.7421875
▁analyze 1.5830078125
▁each 3.953125
▁patient 2.537109375
’ 27.375
s 0.763671875
▁reaction 3.685546875
▁and 2.390625
▁compare 3.509765625
▁it 0.89111328125
▁to 1.2470703125
▁the 0.767578125
▁actual 5.78515625
▁states 7.26171875
▁of 0.71240234375
▁condition 7.2890625
. 0.381103515625
▁More 6.875
▁accurate 3.75
▁answers 4.6328125
▁could 2.5
▁be 0.91357421875
▁obtained 1.0185546875
▁by 1.359375
▁professional 7.4453125
▁psych 2.158203125
olog 0.316162109375
ists 0.0009374618530273438
▁via 8.03125
▁personal 3.962890625
▁communication 4.69140625
▁and 1.8212890625
▁behavior 7.1328125
al 0.347412109375
▁analysis 2.232421875
. 0.2205810546875
▁However 2.72265625
, 0.002574920654296875
▁this 1.9423828125
▁method 2.81640625
▁of 2.3046875
▁research 2.1171875
▁is 0.953125
▁way 7.79296875
▁more 1.740234375
▁resource 6.51171875
- 0.44189453125
int 0.54833984375
ensive 0.00843048095703125
▁and 0.62109375
▁energy 8.65625
- 0.1142578125
consum 0.306884765625
ing 0.0016231536865234375
. 0.58203125
<0x0A> 0.6474609375
Part 5.52734375
icip 0.08819580078125
ants 0.11004638671875
▁were 1.0078125
▁rec 1.5419921875
ru 0.0010633468627929688
ited 8.14199447631836e-05
▁for 1.1396484375
▁six 1.2001953125
▁months 0.020416259765625
▁at 0.48291015625
▁two 0.1151123046875
▁major 0.400146484375
▁pain 0.035919189453125
▁relief 0.027923583984375
▁cent 0.033721923828125
ers 0.004703521728515625
▁in 0.067138671875
▁Israel 0.03564453125
. 0.1497802734375
▁All 3.45703125
▁patients 1.556640625
▁experienced 5.48828125
▁chron 1.9267578125
ic 0.0023365020751953125
▁pain 0.09429931640625
▁for 3.505859375
▁at 0.73583984375
▁least 0.00090789794921875
▁ 1.1103515625
3 1.4375
▁months 0.2354736328125
. 1.0390625
▁The 1.4599609375
▁study 1.9462890625
▁included 2.142578125
▁ 1.130859375
8 2.880859375
9 2.763671875
0 3.568359375
▁participants 1.505859375
, 1.2216796875
▁of 1.7646484375
▁which 0.395751953125
▁ 0.147705078125
4 1.603515625
7 2.46484375
4 2.7578125
▁( 2.1953125
5 0.0888671875
9 11.234375
%) 1.02734375
▁were 0.468994140625
▁treated 4.6796875
▁sole 6.83203125
ly 0.00010406970977783203
▁with 0.466552734375
▁op 0.80712890625
io 0.40283203125
ids 0.197265625
, 1.146484375
▁ 0.580078125
3 1.0712890625
2 2.08984375
9 2.544921875
▁( 0.042755126953125
4 1.1796875
1 1.248046875
%) 0.1358642578125
▁were 1.3076171875
▁treated 0.5478515625
▁with 0.1756591796875
▁MM 0.7763671875
, 0.2568359375
▁and 0.160400390625
▁ 0.1385498046875
7 3.251953125
7 2.416015625
▁( 0.1690673828125
8 3.810546875
. 1.12890625
6 3.10546875
%) 0.054656982421875
▁acquired 9.6796875
▁both 1.1611328125
▁( 7.03125
Fe 10.1328125
ing 2.64453125
old 0.0191192626953125
▁et 1.39453125
▁al 0.016815185546875
., 0.29638671875
▁ 0.009307861328125
2 0.1392822265625
0 0.0002703666687011719
1 0.369140625
7 2.029296875
). 0.12408447265625
▁The 1.341796875
▁remaining 6.9453125
▁ten 8.0859375
▁participants 1.3818359375
▁who 5.6640625
▁did 1.4736328125
▁not 0.006443023681640625
▁receive 1.8330078125
▁ph 3.080078125
arma 0.05914306640625
ce 0.0013990402221679688
ut 1.7881393432617188e-05
ical 0.0033512115478515625
▁op 1.015625
io 0.07769775390625
ids 0.0224761962890625
▁and 1.650390625
▁medical 2.310546875
▁mar 0.042755126953125
iju 0.00432586669921875
ana 7.534027099609375e-05
▁were 1.26953125
▁with 6.07421875
dra 0.133544921875
wn 0.00010669231414794922
▁from 0.255126953125
▁the 0.107421875
▁analysis 4.63671875
▁in 4.796875
▁the 1.1728515625
▁research 4.2890625
. 0.74267578125
▁Therefore 4.83984375
, 0.007778167724609375
▁it 3.77734375
▁is 0.91357421875
▁not 2.724609375
▁possible 0.6396484375
▁to 0.0194244384765625
▁compreh 6.51171875
ens 0.0478515625
ively 0.00836181640625
▁compare 1.890625
▁patients 4.8125
▁taking 4.3125
▁medic 3.87109375
ations 0.46826171875
▁with 0.95361328125
▁those 1.1728515625
▁who 1.123046875
▁do 1.7041015625
▁not 0.007598876953125
. 0.7783203125
<0x0A> 0.65234375
The 1.1015625
▁study 1.685546875
▁conducted 4.7265625
▁a 2.0546875
▁correlation 5.9453125
▁type 7.35546875
▁of 0.44580078125
▁research 2.009765625
▁with 2.865234375
▁variable 7.96484375
▁measures 4.5859375
. 1.2529296875
▁It 2.11328125
▁evaluated 4.3671875
▁the 0.58203125
▁inter 6.359375
dep 3.642578125
end 0.00054168701171875
ence 0.01019287109375
▁of 0.58154296875
▁various 3.892578125
▁factors 1.609375
▁that 2.810546875
▁affected 4.140625
▁the 0.58203125
▁physical 6.8984375
▁and 0.96142578125
▁emot 0.480712890625
ional 0.0003542900085449219
▁condition 1.0029296875
▁of 0.112548828125
▁patients 0.6083984375
▁experien 4.21484375
cing 1.71661376953125e-05
▁chron 0.591796875
ic 0.00045490264892578125
▁pain 0.0266571044921875
. 0.216796875
▁For 3.826171875
▁example 1.0859375
, 0.014678955078125
▁the 1.208984375
▁survey 5.1171875
▁showed 3.421875
▁that 0.419189453125
▁the 1.734375
▁ratio 6.98828125
▁of 0.1224365234375
▁female 4.40625
▁patients 0.79150390625
▁was 1.8642578125
▁remark 9.515625
ably 0.0004987716674804688
▁higher 0.52587890625
▁in 2.6953125
▁the 0.97607421875
▁op 4.5859375
i 4.140625
ates 0.08111572265625
▁group 0.267822265625
▁compared 2.748046875
▁to 0.11444091796875
▁the 0.52783203125
▁MM 0.480712890625
▁group 0.285400390625
. 0.466552734375
▁In 2.99609375
▁turn 4.0078125
, 0.0027179718017578125
▁people 5.96484375
▁on 5.51953125
▁op 1.3876953125
i 0.439453125
ates 0.0031757354736328125
▁were 1.046875
▁more 0.9921875
▁likely 0.382080078125
▁to 0.058929443359375
▁report 3.126953125
▁major 5.9765625
▁de 0.380859375
press 1.228515625
ive 0.003932952880859375
▁dis 0.515625
orders 1.3486328125
. 1.7548828125
<0x0A> 2.427734375
The 1.1083984375
▁question 5.76171875
na 1.3857421875
ires 7.605552673339844e-05
▁used 2.0078125
▁different 8.15625
▁variable 8.75
▁measures 0.79541015625
▁to 1.3564453125
▁collect 2.3359375
▁information 1.9345703125
. 1.6181640625
▁For 1.9736328125
▁example 0.200439453125
, 0.00716400146484375
▁it 4.02734375
▁included 2.470703125
▁compreh 8.65625
ensive 0.0277099609375
▁so 6.87109375
cio 0.01910400390625
- 0.404296875
dem 0.0828857421875
ographic 0.039581298828125
▁data 0.99658203125
: 4.875
▁gender 1.5791015625
, 0.09027099609375
▁age 0.202880859375
, 0.0894775390625
▁country 4.34765625
, 1.484375
▁type 4.375
▁of 0.057159423828125
▁residence 3.845703125
▁( 3.48828125
urban 2.041015625
/ 2.947265625
r 0.06146240234375
ural 0.0004677772521972656
), 0.235595703125
▁years 5.96484375
▁of 0.168212890625
▁education 0.66943359375
, 0.14306640625
▁and 1.845703125
▁employ 3.673828125
ment 0.00406646728515625
▁status 0.44873046875
. 0.174072265625
▁Pat 4.078125
ients 0.09820556640625
▁were 1.154296875
▁also 0.88427734375
▁asked 0.6220703125
▁about 1.12890625
▁their 0.6162109375
▁medical 2.732421875
▁history 0.407958984375
▁over 8.765625
▁the 0.159912109375
▁years 3.978515625
▁and 1.814453125
▁the 1.83984375
▁current 3.3828125
▁presence 5.8203125
▁of 0.053314208984375
▁any 2.6640625
▁severe 4.55859375
▁dise 1.4619140625
ases 7.367134094238281e-05
▁such 4.2109375
▁as 0.004077911376953125
▁heart 2.427734375
▁failure 2.033203125
, 0.1845703125
▁di 1.845703125
ab 0.0017824172973632812
etes 0.004177093505859375
, 0.12115478515625
▁ar 3.80078125
th 0.1275634765625
rit 0.031494140625
is 0.0122528076171875
, 0.040618896484375
▁and 1.5615234375
▁so 0.7275390625
▁on 0.029144287109375
. 0.050506591796875
▁The 1.8837890625
▁third 7.1953125
▁measure 3.908203125
▁of 2.080078125
▁the 0.99658203125
▁question 2.935546875
naire 0.1544189453125
▁was 0.98046875
▁indicated 9.8203125
▁by 0.60400390625
▁information 6.51953125
▁on 1.5791015625
▁any 5.32421875
▁twelve 13.6171875
- 1.1689453125
month 0.35791015625
▁and 5.78515625
▁lifetime 3.201171875
▁drug 4.64453125
▁and 3.474609375
▁alco 0.07525634765625
hol 7.891654968261719e-05
▁consumption 2.576171875
. 0.461181640625
▁In 3.49609375
▁addition 0.80126953125
, 0.1248779296875
▁the 1.154296875
▁record 7.8359375
▁included 1.75
▁a 2.498046875
▁pain 6.40625
▁measurement 4.30859375
▁scale 1.029296875
▁from 3.623046875
▁ 0.45263671875
0 0.435546875
▁to 0.41015625
▁ 0.0065460205078125
1 0.08575439453125
0 0.0740966796875
▁to 4.58984375
▁evaluate 1.5693359375
▁dis 5.90234375
com 0.2119140625
fort 0.0012226104736328125
▁feelings 7.38671875
▁during 3.310546875
▁the 0.9208984375
▁last 1.4453125
▁month 1.59375
. 0.282470703125
<0x0A> 1.158203125
Am 6.94140625
ong 0.011444091796875
▁all 2.37109375
▁participants 1.9677734375
▁in 3.568359375
▁the 0.170654296875
▁study 0.371337890625
, 0.0538330078125
▁ 0.66015625
4 1.7646484375
2 2.72265625
. 1.7919921875
2 2.30078125
% 0.14208984375
▁suffered 4.8046875
▁from 0.1368408203125
▁de 1.736328125
pression 0.15771484375
, 1.0595703125
▁and 1.763671875
▁ 0.145751953125
3 1.7138671875
7 2.236328125
% 2.736328125
▁experienced 2.306640625
▁excess 7.8125
ive 0.08685302734375
▁anx 0.258056640625
iety 0.0014104843139648438
. 0.344482421875
▁The 1.4130859375
▁pl 11.1875
ur 0.99365234375
ality 0.00018548965454101562
▁of 0.1912841796875
▁de 3.51953125
press 1.2607421875
ive 0.023468017578125
▁dis 1.80078125
orders 0.057342529296875
▁among 3.7734375
▁patients 1.1884765625
▁in 3.595703125
▁the 0.36181640625
▁op 1.443359375
i 0.96435546875
ates 0.004306793212890625
, 7.1875
▁medical 2.88671875
▁mar 0.01995849609375
iju 0.005550384521484375
ana 2.9087066650390625e-05
, 0.11041259765625
▁and 0.0625
▁mixed 6.16796875
▁OP 8.84375
MM 5.8046875
▁groups 0.44482421875
▁number 7.98828125
ed 0.00942230224609375
▁ 0.12255859375
5 2.1953125
7 2.486328125
. 0.20654296875
1 2.3671875
%, 0.2454833984375
▁ 0.004161834716796875
2 3.02734375
2 2.435546875
. 0.10321044921875
3 2.224609375
%, 0.113525390625
▁and 0.0322265625
▁ 0.002704620361328125
5 3.21875
1 2.552734375
. 0.1663818359375
4 2.14453125
%, 0.3876953125
▁respectively 0.0092315673828125
. 0.287109375
▁The 1.4638671875
▁pl 4.56640625
ur 0.0214996337890625
ality 3.0159950256347656e-05
▁of 0.04010009765625
▁anx 0.9130859375
iety 0.0105743408203125
▁contained 11.0390625
▁ 0.548828125
4 1.572265625
8 2.37890625
. 0.0633544921875
4 2.30859375
% 0.50439453125
▁among 1.44921875
▁OP 6.421875
▁patients 9.0625
, 0.26953125
▁ 0.09527587890625
2 1.494140625
1 2.416015625
. 0.1312255859375
5 2.4296875
% 0.01108551025390625
▁among 0.421630859375
▁MM 0.338134765625
▁patients 0.2423095703125
, 0.01148223876953125
▁and 0.01314544677734375
▁ 0.036376953125
3 1.234375
8 2.6484375
. 0.160400390625
7 2.291015625
% 0.0129852294921875
▁among 0.2332763671875
▁OP 4.07421875
MM 0.2120361328125
▁participants 3.607421875
. 0.225341796875
▁Pat 5.8359375
ients 0.0213623046875
▁who 2.376953125
▁took 2.966796875
▁strong 8.1953125
▁op 1.2607421875
i 1.3984375
ates 0.003238677978515625
▁were 1.751953125
▁t 8.9453125
ended 1.2314453125
▁to 0.01275634765625
▁place 10.3359375
▁their 3.6796875
▁pain 2.658203125
▁on 3.443359375
▁a 0.896484375
▁scale 2.306640625
▁of 0.6396484375
▁ 0.361083984375
9 2.80859375
▁to 1.369140625
▁ 0.01534271240234375
1 0.023468017578125
0 0.092529296875
▁( 2.55859375
Fe 1.623046875
ing 0.0073089599609375
old 0.00038743019104003906
▁et 0.02880859375
▁al 0.0007462501525878906
., 0.006595611572265625
▁ 0.0014257431030273438
2 0.000484466552734375
0 2.372264862060547e-05
1 0.0016965866088867188
7 0.01194000244140625
). 0.0489501953125
▁They 4.7109375
▁were 1.2763671875
▁also 1.3828125
▁an 8.8515625
gu 4.56640625
ished 0.0295867919921875
▁em 8.5546875
otion 0.00904083251953125
ally 0.0029125213623046875
▁and 1.1162109375
▁react 6.828125
ed 0.057586669921875
▁rad 9.5234375
ically 0.0023956298828125
▁neg 5.3671875
atively 0.0008697509765625
▁to 0.346923828125
▁almost 5.2421875
▁all 1.2119140625
▁survey 8.4609375
▁questions 0.6279296875
. 0.29296875
▁Pat 4.21484375
ients 0.007526397705078125
▁who 1.138671875
▁took 1.548828125
▁only 5.46875
▁MM 0.8837890625
▁or 3.224609375
▁mixed 3.40625
▁medic 2.580078125
ations 0.33056640625
▁course 12.71875
▁had 2.45703125
▁a 1.2841796875
▁significantly 2.55859375
▁more 4.08984375
▁stable 3.419921875
▁emot 1.185546875
ional 0.007099151611328125
▁state 0.81884765625
▁and 1.4169921875
▁cop 5.5078125
ed 0.8349609375
▁with 0.71875
▁pain 1.4541015625
▁more 1.6923828125
▁manage 6.97265625
able 2.421875
. 0.52001953125
<0x0A> 0.7109375
One 5.16015625
▁of 0.60791015625
▁the 0.01751708984375
▁major 2.541015625
▁limitations 2.76953125
▁is 3.876953125
▁the 0.513671875
▁ins 4.74609375
u 0.0181884765625
fficient 0.1217041015625
ly 4.6796875
▁high 2.9921875
▁response 2.9921875
▁rate 0.11712646484375
, 2.65625
▁ 4.640625
5 1.9208984375
7 2.044921875
% 2.123046875
▁instead 7.265625
▁of 0.005367279052734375
▁ 0.70849609375
7 1.5283203125
0 1.4560546875
% 1.1123046875
▁( 1.623046875
Fe 0.2489013671875
ing 0.0034332275390625
old 0.00044345855712890625
▁et 0.0061798095703125
▁al 0.0005125999450683594
., 0.004474639892578125
▁ 0.001125335693359375
2 0.00037097930908203125
0 1.71661376953125e-05
1 0.0008082389831542969
7 0.005886077880859375
). 0.035888671875
▁It 2.673828125
▁can 3.294921875
▁be 0.419921875
▁fairly 8.3359375
▁explained 1.4580078125
▁by 0.1707763671875
▁the 0.331787109375
▁weak 8.2421875
▁focus 7.11328125
▁of 0.472900390625
▁respond 6.2890625
ents 0.1295166015625
▁who 3.5234375
▁have 4.0390625
▁overcome 8.0703125
▁severe 2.24609375
▁pain 0.490966796875
▁sens 8.6796875
ations 1.1279296875
▁and 1.185546875
▁de 4.18359375
press 1.7314453125
ive 0.2607421875
▁episodes 3.931640625
. 0.59521484375
▁It 3.349609375
▁is 0.828125
▁not 2.6484375
▁clear 4.23828125
▁how 1.67578125
▁to 3.560546875
▁use 5.40625
▁these 3.052734375
▁statistics 3.3515625
, 2.533203125
▁as 1.4072265625
▁they 1.375
▁still 6.07421875
▁may 4.78515625
▁be 1.3330078125
▁relevant 5.2578125
▁for 1.40234375
▁the 1.8544921875
▁overall 4.47265625
▁analysis 3.06640625
. 1.0625
